UCLA and North Texas cardiologists debate universal AFib monitoring at HRS 2026, with concerns over data overload vs. disease ...
Stanford's Dr. Perez shows Apple Watches detect AFib with 86% accuracy, offering accessible cardiac monitoring as 115M ...
OMRON Healthcare Co., Ltd., a global leader in clinically proven medical devices for home health monitoring and treatment, today announced its support for May Measurement Month 2026, the annual blood ...
Galaxy Watch AFib monitoring has been approved by the FDA. Samsung will bring this feature to the Galaxy Watch 6 first. Other Galaxy Watches will get the feature shortly afterward. Irregular heart ...
Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).
The Skeptical Cardiologist received an email last week from a patient with paroxysmal atrial fibrillation (Afib) saying she was having an episode, documented on her Apple Watch and Kardia device, but ...
Real-world data presented at HRS 2026 add to the body of evidence supporting a shift away from short-duration Holter monitoring toward up to 14 days of continuous, uninterrupted m ...
- As the world’s first ring-type medical device to monitor heart signals, CART-I continually measures atrial fibrillation 24/7 - In-house developed AI technology is used to provide significant medical ...
Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI ...
Using a wearable device, such as a smart watch, to track health data and symptoms, is supposed to help people monitor their health and address symptoms as quickly as possible to spur positive health ...
AMSTERDAM -- Edoxaban (Savaysa) didn't improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial ...
MedPage Today on MSN
Upfront pulsed field ablation shows efficacy in persistent AFib
AVANT GUARD trial meets expectations despite pause for safety modifications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results